Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-18

Clinical Trial Update: Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION) [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated whether adding vildagliptin to metformin improves outcomes compared with metformin up-titration in Chinese adults with type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vildagliptin (vildagliptin)
  • metformin (metformin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED